Virtus Fund Advisers’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-48
Closed -$15.6K 136
2024
Q1
$15.6K Sell
48
-108
-69% -$26.5K 0.06% 112
2023
Q4
$29.7K Hold
156
0.18% 83
2023
Q3
$31.1K Hold
156
0.22% 72
2023
Q2
$44.5K Hold
156
0.31% 56
2023
Q1
$33.8K Hold
156
0.24% 73
2022
Q4
$32.1K Buy
+156
New +$39.4K 0.23% 76

Other funds holding SWAV

Virtus Fund Advisers's SWAV Position: Q2 2024 in Review

Virtus Fund Advisers sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 48 shares — an estimated $15.6K sold.

Virtus Fund Advisers first reported a position in SWAV in Q4 2022 and held it in 6 quarters. The position peaked at $44.5K in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Virtus Fund Advisers reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Virtus Fund Advisers sold 48 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $15.6K.
  • Virtus Fund Advisers first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Virtus Fund Advisers's Shockwave Medical, Inc. Common Stock position peaked at $44.5K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Virtus Fund Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.